Finance Home - My Yahoo - Yahoo! - Help

Monday, November 30, 2009, 8:12PM ET - U.S. Markets Closed. Dow  0.34% Nasdaq  0.29%

MAP Pharmaceuticals, Inc. (MAPP)

At 4:00PM ET: 9.05   0.06 (0.66%)

MORE ON MAPP

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Thu, Nov 12, 2009 • MAP Pharmaceuticals gets $60M financing facility AP (Thu, Nov 12) • MAP PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex EDGAR Online (Thu, Nov 12) • MAP Pharmaceuticals Secures $60 Million Committed Equity Financing Facility PR Newswire (Thu, Nov 12) Wed, Nov 11, 2009 • MAP PHARMACEUTICALS, INC. Financials EDGAR Online Financials (Wed, Nov 11) • MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference PR Newswire (Wed, Nov 11) Sun, Nov 8, 2009 • New Star Analyst Rankings for MAP Pharmaceuticals, Inc. StarMine (Sun, Nov 8) Fri, Nov 6, 2009 • MAP PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, Nov 6) Thu, Nov 5, 2009 • MAP Pharmaceuticals goes from Q3 loss to $19.3M profit at bizjournals.com (Thu, Nov 5) • MAP PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online (Thu, Nov 5) • MAP Pharmaceuticals Reports Third Quarter of 2009 Financial Results PR Newswire (Thu, Nov 5) Fri, Oct 30, 2009 • MAP PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events EDGAR Online (Fri, Oct 30) Thu, Oct 29, 2009 • MAP Pharmaceuticals Completes Interim Safety Review of LEVADEX(TM) Open-Label Safety Extension in More Than 400 Patients PR Newswire (Thu, Oct 29) Tue, Oct 20, 2009 • Biotech Mergers And Acquisitions Will Accelerate According To Wedbush Morgan Expert Analyst As More Expensive Phase III Trials Force Small Biotech Companies Into Large Pharma Distribution And Finance Organizations Wall Street Transcript (Tue, Oct 20) Thu, Oct 1, 2009 • [$$] Talecris Pops 11% in Debut at The Wall Street Journal Online (Thu, Oct 1) Tue, Sep 22, 2009 • 'Headache' Publication Describes Potential Mechanistic Rationale for LEVADEX(TM) Favorable Adverse Event Profile PR Newswire (Tue, Sep 22) Thu, Sep 10, 2009 • MAP PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events EDGAR Online (Thu, Sep 10) • MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society PR Newswire (Thu, Sep 10) Wed, Sep 2, 2009 • Movers roundup: Joy Global, Capital One AP (Wed, Sep 2) • Analyst says new Levadex data could lift MAP stock AP (Wed, Sep 2) • MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences PR Newswire (Wed, Sep 2) Older Headlines - Download Recent Headlines View headlines from: Wed, Sep 2, 2009Wed, Aug 26, 2009Wed, Aug 19, 2009Wed, Aug 12, 2009Wed, Aug 5, 2009Wed, Jul 29, 2009Wed, Jul 22, 2009Wed, Jul 15, 2009Wed, Jul 8, 2009Wed, Jul 1, 2009 Add MAPP News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage